A quantitative reverse transcriptase-polymerase chain reaction for HIV-1-specific RNA species

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Understanding human immunodeficiency virus type I (HIV-1) RNA expression is critical for studying viral pathogenesis.
• Accurate quantification of HIV-1 RNA in different cellular states (latent vs. productive infection) is essential for research and potential therapeutic strategies.

Purpose of the Study:

• To develop and validate a quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) assay for precise measurement of HIV-1-specific RNA.
• To determine the copy number of multiply-spliced, unspliced, and total HIV-1 RNA species per cell and per microgram of total cellular RNA.

Main Methods:

• Development of a quantitative RT-PCR assay using in vitro transcribed RNA standards.
• Application of the assay to latently infected monocytic (U1) and T-lymphocyte (ACH-2) cell lines.
• Analysis of HIV-1 RNA levels before and after stimulation with phorbol esters.

Main Results:

• Latently infected U1 and ACH-2 cell lines express 10^4 to 10^6 copies of total HIV-1 RNA per cell, varying with cellular stimulation.
• A significant increase in unspliced HIV-1 RNA was observed in U1 and ACH-2 cells 24 hours post-stimulation with phorbol esters.
• The study demonstrates that a single integrated HIV-1 provirus can rapidly produce substantial amounts of viral RNA.

Conclusions:

• Quantitative RT-PCR provides a powerful tool for evaluating HIV-1 RNA levels in cell cultures.
• This method is valuable for assessing retroviral load and understanding pathogenesis in both in vitro and potentially in vivo settings.
• The findings highlight the rapid and high-level RNA expression capacity of integrated HIV-1 proviruses upon cellular activation.